HOME >> MEDICINE >> NEWS
Enzyme level linked to death after angioplasty

DALLAS, Aug. 20 A test commonly used to diagnose heart attacks may also identify patients at increased risk of death after balloon angioplasty, according to a study in today's rapid access issue of Circulation: Journal of the American Heart Association.

Blood levels of the enzyme creatine kinase-MB (CK-MB) rise after a heart attack, indicating injury to the heart muscle. Measuring CK-MB is a standard diagnostic test for heart attacks. Several studies have shown that elevated CK-MB is a marker for minor heart attacks and an increased risk of cardiac death after angioplasty and other catheter-based procedures. However, the nature of the relationship between CK-MB and adverse outcomes after angioplasty remains controversial.

Researchers in this study found that people with CK-MB levels more than five times higher than normal after angioplasty or stenting have a "clinically significant" increased risk of death for three to four months after the procedure. This was particularly true for those with other risk factors such as advanced age, heart failure or kidney failure.

Study author Stephen Ellis, M.D., a study author and professor and director of invasive cardiology at the Cleveland Clinic Foundation in Ohio, says the study is one of the largest of its kind. It produced several new findings: (1) a clinically significant risk of death is associated with CK-MB levels greater than five times normal; (2) there is an early period of risk, which appears to extend three to four months after the procedure; (3) the risk is greatest for patients with the highest CK-MB levels, kidney failure, heart failure, incomplete revascularization, advanced age, and high post-procedural C-reactive protein; and (4) treatment with a statin drug may lower the risk of death after a procedure.

"From the clinician's perspective, a major question has been what to do with patients who have an increase in CK-MB after angioplasty," says Ellis. "Our data show pretty clearly
'"/>

Contact: Carole Bullock
carole.bullock@heart.org
214-706-1279
American Heart Association
19-Aug-2002


Page: 1 2 3

Related medicine news :

1. Enzyme linked to mania and schizophrenia impairs higher brain functions
2. Enzyme prevents lung damage in premature infants
3. Enzyme found in blood vessels likely target to treat lung injury
4. Enzyme structure holds key to cocaine, heroin metabolism
5. Enzyme replacement therapy found to effectively treat patients with Fabry disease
6. Enzyme halts muscle waste in mouse models of most-common childhood muscular dystrophy
7. Enzyme could provide continual fat burning
8. Charcoal and forest management could reduce greenhouse gas levels & save lives in Africa
9. Physicians may not be accurate in their confidence levels of their diagnoses, says Pitt study
10. RIT takes eye-tracking research to next level
11. Effects of education level on rates of obesity differ by race

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/12/2017)... ... October 12, 2017 , ... First Healthcare Compliance (FHC), ... will showcase a range of technology and learning solutions at the 68th Annual ... Expo to be held October 14–18, 2017 at the Mandalay Bay Resort in ...
(Date:10/12/2017)... , ... October 12, 2017 , ... ... to meet the demand of today’s consumer and regulatory authorities worldwide. From Children’s ... experts and tested to meet the highest standard. , These products are ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... in post-acute health care, have expanded their existing home health joint venture through ... AccentCare has been operating a joint venture home health company with Asante, delivering ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... HMP ... the recipient of a 2017 Folio Magazine Eddie Digital Award for ‘Best B-to-B Healthcare ... City on October 11, 2017. , The annual award competition recognizes editorial and design ...
(Date:10/12/2017)... ... October 12, 2017 , ... Women-owned and Grand ... Best and Brightest in Wellness® by Best and Brightest. OnSite Wellness will be ... Oct. 20 from 7:30 a.m. to 2 p.m. at the Henry Autograph Collection ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... -- Diplomat Pharmacy, Inc. (NYSE: DPLO ) ... , and named its founder as Diplomat,s chief information ... Tennessee , will operate under Diplomat subsidiary Envoy ... for health care partners to include IT outsourcing, consulting, ... "In an interoperable world, technology delivers comprehensive insight and ...
(Date:9/28/2017)... Hill-Rom Holdings, Inc. (NYSE: HRC), will host ... webcast on Friday, November 3, 2017, beginning at 7:00 ... approximately 8:30 a.m. (CDT) / 9:30 a.m. (EDT). ... performance and guidance for 2018, Hill-Rom executives will also ... performance, and long-range financial outlook through 2020. ...
(Date:9/25/2017)... , Sept. 25, 2017  EpiVax, Inc., ... vaccine design, and immune-engineering today announced the launch ... the development of personalized therapeutic cancer vaccines. EpiVax ... provided exclusive access to enabling technologies to the ... MBA will lead EpiVax Oncology as Chief Executive ...
Breaking Medicine Technology:
Cached News: